ANAL BASALOID CARCINOMA
Clinical trials for ANAL BASALOID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL BASALOID CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL BASALOID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could less be more? new study tests gentler treatment for anal cancer
Disease control OngoingThis study is for people with early-stage anal cancer. It compares a lower-dose chemotherapy and radiation treatment to the standard dose. The goal is to see if the lower dose works just as well to control the cancer but causes fewer side effects and improves quality of life. Abo…
Matched conditions: ANAL BASALOID CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 09:22 UTC
-
Immunotherapy combo shows promise in advanced anal cancer trial
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab to standard chemotherapy works better than chemotherapy alone for people with anal cancer that has spread or cannot be removed. About 205 adults with this type of cancer will receive either the combination or just c…
Matched conditions: ANAL BASALOID CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Immunotherapy after Chemo-Radiation may keep anal cancer at bay
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab after standard chemoradiation helps prevent anal cancer from coming back in patients with high-risk stage II-III disease. About 344 adults with certain types of anal cancer will receive nivolumab or a placebo for up…
Matched conditions: ANAL BASALOID CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:34 UTC